Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID TrialPaulo M. Hoff, Brigitte Van Eyll, Anelisa K. Coutinho et al.|Journal of Clinical Oncology|2014Cited by 48
Vispa-Cel, an Allogeneic Anti-CD19 CAR-T cell Therapy with a PD-1 Knockout, In Patients with relapsed/refractory B cell Non-Hodgkin Lymphoma (r/r B-NHL): Updated Results from the Antler Phase 1 Clinical TrialMehdi Hamadani, Susan O'Brien, Houston Holmes et al.|Transplantation and Cellular Therapy|2026Cited by 0